| Report ID | 281523 |
| Drug Identification Number | 02301334 |
| Brand name | BRIMONIDINE P |
| Common or Proper name | BRIMONIDINE |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIMONIDINE TARTRATE |
| Strength(s) | 0.15% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10 ML |
| ATC code | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-24 |
| Estimated end date | 2026-06-11 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-26 | French | Compare |
| v1 | 2026-03-26 | English | Compare |
Showing 1 to 2 of 2